iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research

Area of Science:

• Pharmacogenomics
• Cancer Research
• Bioinformatics

Background:

• Pharmacogenetic studies have yielded predictive models for anticancer drug efficacy.
• Existing valuable models are underutilized in cancer research due to data integration and standardization challenges.

Purpose of the Study:

• To develop a comprehensive resource, investigating genetic model of drug response (iGMDR), that integrates pharmacogenetic data.
• To standardize and consolidate pharmacogenetic models from various studies and omics data types.
• To facilitate the use of these integrated models for advancing cancer therapy development.

Main Methods:

• Integrated pharmacogenetic models from in vitro and in vivo studies.
• Incorporated diverse omics data from multiple technical systems.
• Developed a standardized process for data integration.

Main Results:

• Created the iGMDR resource, a centralized hub for pharmacogenetic drug response models.
• Demonstrated a standardized approach for integrating heterogeneous pharmacogenetic and omics data.
• Provided a platform for users to gain insights into cancer pharmacogenetics.

Conclusions:

• The iGMDR resource addresses the need for integrated and standardized pharmacogenetic data.
• Standardized integration of pharmacogenetic models can significantly enhance cancer research and drug development.
• iGMDR is a valuable, freely accessible tool for the scientific community at https://igmdr.modellab.cn.